PLoS ONE (Jan 2020)

Novel variant in the CNNM2 gene associated with dominant hypomagnesemia.

  • Alejandro García-Castaño,
  • Leire Madariaga,
  • Montserrat Antón-Gamero,
  • Natalia Mejia,
  • Jenny Ponce,
  • Sara Gómez-Conde,
  • Gustavo Pérez de Nanclares,
  • Ana Belén De la Hoz,
  • Rosa Martínez,
  • Laura Saso,
  • Idoia Martínez de LaPiscina,
  • Inés Urrutia,
  • Olaia Velasco,
  • Aníbal Aguayo,
  • Luis Castaño,
  • Sonia Gaztambide

DOI
https://doi.org/10.1371/journal.pone.0239965
Journal volume & issue
Vol. 15, no. 9
p. e0239965

Abstract

Read online

The maintenance of magnesium (Mg2+) homeostasis is essential for human life. The Cystathionine-β-synthase (CBS)-pair domain divalent metal cation transport mediators (CNNMs) have been described to be involved in maintaining Mg2+ homeostasis. Among these CNNMs, CNNM2 is expressed in the basolateral membrane of the kidney tubules where it is involved in Mg2+ reabsorption. A total of four patients, two of them with a suspected disorder of calcium metabolism, and two patients with a clinical diagnosis of primary tubulopathy were screened for mutations by Next-Generation Sequencing (NGS). We found one novel likely pathogenic variant in the heterozygous state (c.2384C>A; p.(Ser795*)) in the CNNM2 gene in a family with a suspected disorder of calcium metabolism. In this family, hypomagnesemia was indirectly discovered. Moreover, we observed three novel variants of uncertain significance in heterozygous state in the other three patients (c.557G>C; p.(Ser186Thr), c.778A>T; p.(Ile260Phe), and c.1003G>A; p.(Asp335Asn)). Our study shows the utility of Next-Generation Sequencing in unravelling the genetic origin of rare diseases. In clinical practice, serum Mg2+ should be determined in calcium and PTH-related disorders.